Category Archives: Covering medical studies

Search for fountain of youth drives testosterone replacement industry

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in Kaiser Health News, The Atlantic.com, New America Media, AARP.com and other outlets. She is a senior fellow at the Center for Health, Media & Policy at Hunter College in New York City, and co-produces HealthStyles for WBAI-FM/Pacifica Radio.

Photo: Maxwell GS via Flickr

You know those ads on late-night radio or in the back of some magazines for testosterone replacement therapy? Hate to be the bearer of bad news, but for older men that’s no real path to a male fountain of youth.

Like it or not, low testosterone is a normal part of aging and “fixing” it can be risky. Despite some news reports on the benefits of testosterone replacement therapy, several recent studies show that the harms may outweigh benefits. Continue reading

Research: Finesse, transparency key when reporting foodborne illness outbreaks

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: NIH Image Gallery via FlickrSalmonella bacteria invade an immune cell.

A mainstay of health reporting is covering outbreaks of foodborne illness, whether it’s salmonella in peanut butter (and its criminal consequences) or listeria in cantaloupes or ice cream. While the Centers for Disease Control and Prevention maintains a robust site documenting food-borne illness outbreaks, by the time the CDC cites a case on its website, the outbreak often already been in the news since potential outbreaks are first investigated by local and state health departments.

How do these smaller agencies decide how and when to publicize details about a suspected or confirmed outbreak? Continue reading

Study: Newspaper coverage rarely reflects medical evidence over time

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: Binuri Ranasinghe via Flickr

Journalists are in love with reporting new findings about a disease and a particular risk factor, but they are not so keen on following what happens later and reporting on whether the finding was replicated – and just over half the time is later disproved.

This comes from a recent study in PLOS ONE by authors who previously found that journalists tend to favor initial findings over subsequent findings on the same outcome. Continue reading

Assessing the red flags in a study … annotated

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

I’m frequently asked on social media for my thoughts on a particular study. In this situation, I thought the quick analysis I did may be instructive for others, so I’ve Storified it here, along with additional commentary and resources. Continue reading

P-hacking, self-plagiarism concerns plague news-friendly nutrition lab

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: Dominic Rooney via Flickr

Some of the most difficult research to make sense of comes from nutrition science. It is difficult, expensive and labor-intensive to conduct randomized controlled trials in nutrition, in part because they require randomizing what people eat and then ensuring they eat what they’re supposed to – no more and no less.

Even when such trials are finished (often at in-patient labs), the populations are usually small and somewhat homogenous, thus reducing the generalizability and overall clinical utility of results. Continue reading